Association of the C3953T (rs1143634) variant of the interleukin 1 beta gene with the features of a complicated course of COVID-19-associated pneumonia
- PMID: 38720147
- DOI: 10.1007/s11033-024-09569-4
Association of the C3953T (rs1143634) variant of the interleukin 1 beta gene with the features of a complicated course of COVID-19-associated pneumonia
Abstract
Background: The pro-inflammatory cytokine IL-1 plays an important role in severe COVID-19. A change in IL-1 production may be associated with a mutation in the IL1Β gene. Our study analyzed the impact of the IL1Β gene variants (rs1143634) on disease progression in patients with severe COVID-19 pneumonia, taking into account treatment strategies.
Methods and results: The study enrolled 117 patients with severe COVID-19 pneumonia. The IL1Β gene variants were identified using the polymerase chain reaction-restriction fragment length polymorphism method. In the group of patients, the following genotype frequencies were found based on the investigated rs1143634 variant of the IL1Β gene: CC-65.8%, CT-28.2%, and TT-6.0%. Our results showed that the group of patients with the T allele of the IL1Β gene had higher leukocyte counts (p = 0.040) and more pronounced lymphopenia (p = 0.007). It was determined that patients carrying the T allele stayed on ventilators significantly longer (p = 0.049) and required longer treatment with corticosteroids (p = 0.045).
Conclusion: Identifying variants of the IL1Β gene can be used as a predictive tool for assessing the severity of COVID-19 pneumonia and tailoring personalized treatment strategies. Further research with a larger patient cohort is required to validate these findings.
Keywords: C3953T; COVID-19; Interleukin 1 beta; Pneumonia; rs1143634.
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
References
-
- Worldometers (2023). https://www.worldometers.info/coronavirus/ Accessed 19 Mar 2024.
-
- HO, World Health Organization. https://www.who.int/news-room/speeches/item/who-director-general-s-openi... /Accessed 19 Mar 2024
-
- Vatansever HS, Becer E (2020) Relationship between IL-6 and COVID-19: to be considered during treatment. Future Virol. https://doi.org/10.2217/fvl-2020-0168 - DOI - PMC
-
- Tanaka T, Narazaki M, Kishimoto T (2014) IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol 6(10):a016295. https://doi.org/10.1101/cshperspect.a016295 - DOI - PMC - PubMed
-
- Gallenga CE, Pandolfi F, Al C et al (2019) Interleukin-1 family cytokines and mast cells: activation and inhibition. J Biol Regul Homeost Agents 33(1):1–6 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
